SAN FRANCISCO, May 10, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ: MGNX) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/mgnx Contact the Firm Now: This email address is being protected from spambots. You need JavaScript enabled to view it. 844-916-0895
Mon, 23 Sep 2024 13:30:00 GMT Following this news, MGNX's stock declined 77.4% due to a drop of $11.36/share. WHAT'S NEXT? If you suffered a loss in MacroGenics stock during the relevant time frame - even if you still hold ...
Tue, 17 Sep 2024 14:29:00 GMT Following this news, MGNX's stock declined 77.4% due to a drop of $11.36/share. WHAT'S NEXT? If you suffered a loss in MacroGenics stock during the relevant time frame - even if you still hold ...
Tue, 17 Sep 2024 09:30:00 GMT Following this news, MGNX's stock declined 77.4% due to a drop of $11.36/share. WHAT'S NEXT? If you suffered a loss in MacroGenics stock during the relevant time frame - even if you still hold ...
Sun, 15 Sep 2024 13:07:00 GMT Following this news, MGNX's stock declined 77.4% due to a drop of $11.36/share. WHAT'S NEXT? If you suffered a loss in MacroGenics stock during the relevant time frame - even if you still hold ...
Fri, 13 Sep 2024 13:30:00 GMT Following this news, MGNX's stock declined 77.4% due to a drop of $11.36/share. WHAT'S NEXT? If you suffered a loss in MacroGenics stock during the relevant time frame - even if you still hold ...